{'fraction_non_alphanumeric': 0.04918032786885246, 'fraction_numerical': 0.034972677595628415, 'mean_word_length': 4.925566343042071, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa.

SETTING
Guguletu and Nyanga areas of Cape Town, South Africa.


OBJECTIVE
To evaluate the affordability and cost-effectiveness of community involvement in tuberculosis (TB) care.


DESIGN
A cost-effectiveness analysis comparing treatment for new smear-positive pulmonary and retreatment TB patients in two similar townships, one providing clinic-based-care with community-based observation options available for its TB patients (Guguletu) and one providing clinic-based care only, with no community-based observation of treatment (Nyanga). Costs were assessed from a societal perspective in 1997 US$, and cost-effectiveness was calculated as the cost per patient successfully treated.


RESULTS
TB treatment in Guguletu was more cost-effective than TB treatment in Nyanga for both new and retreatment patients ($726 vs. $1201 and $1419 vs. $2058, respectively). This reflected both lower costs ($495 vs. $769 per patient treated for new cases; $823 vs. $1070 per patient treated for retreatment cases) and better treatment outcomes (successful treatment rate 68% vs. 64% and 58% vs. 52% for new and retreatment patients, respectively). Within Guguletu, community-based care was more than twice as cost-effective as clinic-based care ($392 vs. $1302 per patient successfully treated for new patients, and $766 vs. $2008 for retreatment patients), for similar reasons (e.g., for new cases, $314 vs. $703 per patient treated, successful treatment rate 80% vs. 54%).


CONCLUSION
Community involvement in TB care can improve the affordability and cost-effectiveness of TB treatment in urban South Africa. Expansion in the Western Cape and in similar areas of the country is worthy of serious consideration by planners and policy-makers.